Signaling for ethanol-induced apoptosis and repair in vitro

Clinical Biochemistry

Volumn 34, Issue 3, 2001, Pages 219-227

  Katz, Gady G ^a,b   Shear, Neil H ^a,b   Malkiewicz, Izabella M ^a,b   Valentino, Karen ^c   Neuman, Manuela G ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PFIZER INC   (United States)

Author keywords

Alcohol Induced Liver Damage; Apoptosis; Caspase; CYP 2EI; Hep G2; Mitochondria; Polyenylphosphatidylcholine (PPC)

Indexed keywords

ALCOHOL; CASPASE; CASPASE 3 INHIBITOR; CASPASE INHIBITOR; DNA FRAGMENT; PHOSPHATIDYLCHOLINE; POLYENE PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL REGENERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY;

APOPTOSIS; CASPASES; CELL LINE; DNA REPAIR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHANOL; HEPATOCYTES; HUMANS; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON; SIGNAL TRANSDUCTION;

EID: 0034971489     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(01)00218-1     Document Type: Article

References (62)

1. Cell suicide for beginners
2. To die or not to die: An overview of apoptosis and its role in disease
3. Apoptosis: Clinical relevance and pharmacological manipulation
4. Essential roles of the Fas ligand in the development of hepatitis
5. Apoptosis in liver disease
6. Apoptosis and the liver: Relevance for the hepato-biliary-pancreatic surgeon
7. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation
8. Apoptosis in the human liver during allograft rejection and end-stage liver disease
9. Role of cytokines in ethanol-induced hepatocytotoxicity in Hep G2 cells
10. Ethanol-induced apoptosis in vitro
11. Increased hepatotoxicity from Acetaminophen in human hepatocytes pretreated with ethanol in cell culture
12. Inducers of cytochrome P450 2E1 enhances methotrexate-induced hepatocytotoxicity
13. Drug-induced apoptosis
14. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO1/Fas) mediated apoptosis
15. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis
16. Serum Fas ligand in patients with primary biliary cirrhosis reflects severity of the disease: Effect of treatment with ursodeoxycholic acid
17. Electron microscopic study on apoptosis in primary biliary cirrhosis
18. Beta-N-Acetyl hexosaminidase (B-NAH) serum levels after endotoxin administration into the portal vein in the rat
19. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-α-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model
20. Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors
21. Hepatocyte apoptosis triggered by natural substances (Cytokines, other endogenous molecules and foreign toxins)
22. Caspases: Enemies within
23. Identification and characterization of murine caspase-14, a new member of the caspase family
24. Inhibition of human caspases by peptide-based and macromolecular inhibitors
25. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation
26. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathologic conditions
27. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
28. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death
29. Inhibition of c-Myc expression sensitizes hepatocytes to tumor necrosis factor-induced apoptosis and necrosis
30. Caspases: Decoders of apoptotic signals during mammary involution. Caspase activation during involution
31. Role of caspases and NF-kappaB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis
32. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes
33. Death receptors in liver biology and pathobiology
34. Membrane oligomerization and cleavage activates caspase-8 (FLICE/MACHa1) death signal
35. FLICE induced apoptosis in a cell-free system
36. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
37. Heavy membrane-associated caspase 3: Identification, isolation, and characterization
38. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism
39. ATP-dependent steps in apoptotic signal transduction
40. Oligodendrocyte apoptosis mediated by caspase activation
41. Activation of membrane-associated procaspase-3 is regulated by Bcl-2
42. Granzyme B mimics apical caspases. Description of a unified pathway for trans-activation of executioner caspase-3 and -7
43. Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine
44. Disposition and hepatoprotection by phosphatidyl choline liposomes in mouse liver
45. Hepatic uptake and antihepatotoxic properties of vitamin E and liposomes in the mouse
46. The influence of "essential" phospholipids (EPL) on phase-I- and phase-II-reactions and on the glutathione status in the liver of aging rats
47. Portal fibroblasts and myofibroblasts in baboons after long-term alcohol consumption
48. Polyenylphosphatidylcholine attenuates nonalcoholic hepatic fibrosis and accelerates its regression
49. Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aa3 content and changes in phospholipids
50. Polyenylphosphatidylcholine attenuates alcohol induced fatty liver and hyperlipemia in rats
51. Ethanol potentates tumor necrosis factor cytotoxicity in hepatoma cells and in primary rat hepatocytes by promoting induction of the permeability transition
52. Modeling in vitro ethanol-induced apoptosis with caspase-3 inhibitor in normal human hepatocytes
53. Ethanol-inducible cytochrome P450 2E1: Genetic polymorphism, regulation and possible role in the etiology of alcohol- induced liver disease
54. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: Studies with isolated mitochondria and rat hepatocytes
55. Modulation of liver-specific cellular response to ethanol in vitro in Hep G2 cells
56. In vitro, assessment of the ethanol-induced hepatotoxicity on Hep G2 cell line
57. Effect of tauroursodeoxycholic acid and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line
58. Cytokines and alcoholic liver disease
59. Plasma tumor necrosis factor- a predicts long term survival in severe alcoholic hepatitis
60. Effects of prolonged ethanol intake in man: Role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver
61. Modulation of caspase 3 activity and anti Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide
62. Attenuation of alcohol-induced apoptosis of hepatocytes in rat livers by polyenylphosphatidilcholine (PPC)